Cessation of oral anticoagulants in antiphospholipid syndrome.

about

Cessation of oral anticoagulants in antiphospholipid syndrome.

Item

http://www.wikidata.org/entity/Q50765317

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Cessation of oral anticoagulants in antiphospholipid syndrome.

@en

Cessation of oral anticoagulants in antiphospholipid syndrome.

@nl

type

Item

label

Cessation of oral anticoagulants in antiphospholipid syndrome.

@en

Cessation of oral anticoagulants in antiphospholipid syndrome.

@nl

prefLabel

Cessation of oral anticoagulants in antiphospholipid syndrome.

@en

Cessation of oral anticoagulants in antiphospholipid syndrome.

@nl

P1476

Cessation of oral anticoagulants in antiphospholipid syndrome.

@en

P2093

A Elmaleh-Sachs

http://www.w3.org/2001/XMLSchema#string

A Mekinian

http://www.w3.org/2001/XMLSchema#string

A Michon

http://www.w3.org/2001/XMLSchema#string

B Castel

http://www.w3.org/2001/XMLSchema#string

C Comarmond

http://www.w3.org/2001/XMLSchema#string

C Goujard

http://www.w3.org/2001/XMLSchema#string

C Veyssier-Belot

http://www.w3.org/2001/XMLSchema#string

D Khau

http://www.w3.org/2001/XMLSchema#string

D Saadoun

http://www.w3.org/2001/XMLSchema#string

E Oziol

http://www.w3.org/2001/XMLSchema#string

P2860

Management of antiphospholipid antibody syndrome: a systematic review

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.

Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies.

14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends.

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature.

The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.

Rituximab usage in systemic lupus erythematosus-associated antiphospholipid syndrome: A single-center experience.

Clinical course of high-risk patients diagnosed with antiphospholipid syndrome.

P304

1291-1296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0961203317699285

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Patrice Cacoub

Jean-Charles Piette

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28355985

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation